| scholarly article | Q13442814 |
| P50 | author | Mauro Biffoni | Q37391458 |
| Anna Teresa Palamara | Q56461530 | ||
| David C. Montefiori | Q63302725 | ||
| Mark G. Lewis | Q66732036 | ||
| Andrea Savarino | Q124614331 | ||
| Luca Shytaj | Q27531982 | ||
| Marjorie Robert-Guroff | Q30651738 | ||
| P2093 | author name string | Celia LaBranche | |
| Jonah B Sacha | |||
| Nicholas Farrell | |||
| Hye Kyung Chung | |||
| Diego Vargas-Inchaustegui | |||
| Ranajit Pal | |||
| Eric Arts | |||
| Gabrielle Nickel | |||
| P2860 | cites work | CD8+ and CD4+ cytotoxic T cell escape mutations precede breakthrough SIVmac239 viremia in an elite controller | Q36394661 |
| Chronic innate immune activation as a cause of HIV-1 immunopathogenesis | Q36510689 | ||
| Preclinical evaluation of HIV eradication strategies in the simian immunodeficiency virus-infected rhesus macaque: a pilot study testing inhibition of indoleamine 2,3-dioxygenase | Q36554031 | ||
| HIV-1 resistance to maraviroc conferred by a CD4 binding site mutation in the envelope glycoprotein gp120 | Q36559608 | ||
| CD8 down-regulation and functional impairment of SIV-specific cytotoxic T lymphocytes in lymphoid and mucosal tissues during SIV infection | Q36850473 | ||
| Investigational treatment suspension and enhanced cell-mediated immunity at rebound followed by drug-free remission of simian AIDS. | Q37109010 | ||
| Mosaic genome structure of simian immunodeficiency virus from west African green monkeys | Q37633735 | ||
| HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals | Q37771138 | ||
| A cure for AIDS: a matter of timing? | Q38165451 | ||
| High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys | Q39592712 | ||
| Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses | Q40757015 | ||
| Auranofin: repurposing an old drug for a golden new age. | Q41474201 | ||
| Therapeutic envelope vaccination in combination with antiretroviral therapy temporarily rescues SIV-specific CD4⁺ T-cell-dependent natural killer cell effector responses in chronically infected rhesus macaques | Q41519074 | ||
| A candidate anti-HIV reservoir compound, auranofin, exerts a selective 'anti-memory' effect by exploiting the baseline oxidative status of lymphocytes. | Q41844700 | ||
| Breaking free of sample size dogma to perform innovative translational research | Q42117164 | ||
| Research on very early ART in neonates at risk of HIV infection | Q43172424 | ||
| Impact of immune interventions on proviral HIV-1 DNA decay in patients receiving highly active antiretroviral therapy | Q43818110 | ||
| Molecular methods for evaluation of virological status of nonhuman primates challenged with simian immunodeficiency or simian-human immunodeficiency viruses. | Q44065795 | ||
| Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology | Q45743923 | ||
| Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. | Q48946089 | ||
| Gold drug auranofin restricts the viral reservoir in the monkey AIDS model and induces containment of viral load following ART suspension. | Q51012086 | ||
| CD8+ T-cell responses to different HIV proteins have discordant associations with viral load | Q57259602 | ||
| Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load | Q58034113 | ||
| Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells. | Q64922882 | ||
| The interaction of auranofin and buthionine sulfoximine blocks activation of human peripheral T lymphocytes | Q72613581 | ||
| Development of real-time PCR assays for quantitation of simian betaretrovirus serotype-1, -2, -3, and -5 viral DNA in Asian monkeys | Q81571940 | ||
| Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant | Q27323780 | ||
| A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model | Q27344720 | ||
| Mature HIV-1 capsid structure by cryo-electron microscopy and all-atom molecular dynamics | Q27678383 | ||
| Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine) | Q28317414 | ||
| Endogenous lentivirus in Malayan colugo (Galeopterus variegatus), a close relative of primates | Q28654667 | ||
| Phylogeny.fr: robust phylogenetic analysis for the non-specialist | Q29547666 | ||
| Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation | Q29615068 | ||
| Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies | Q29619015 | ||
| HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation | Q29619611 | ||
| Immune activation and HIV persistence: considerations for novel therapeutic interventions | Q33698781 | ||
| Functional cure of SIVagm infection in rhesus macaques results in complete recovery of CD4+ T cells and is reverted by CD8+ cell depletion | Q33987485 | ||
| Sustained viral response in a hepatitis C virus-infected chimpanzee via a combination of direct-acting antiviral agents | Q34152326 | ||
| Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma | Q34332166 | ||
| Biomarker reveals HIV's hidden reservoir | Q34350403 | ||
| CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cells | Q34395160 | ||
| Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control | Q34435052 | ||
| Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism | Q34482589 | ||
| Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases | Q34539993 | ||
| Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study | Q34629153 | ||
| Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations | Q35521811 | ||
| Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes | Q35641386 | ||
| NK and CD4+ T cell cooperative immune responses correlate with control of disease in a macaque simian immunodeficiency virus infection model | Q36140156 | ||
| Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal | Q36164175 | ||
| Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following simian immunodeficiency virus challenges of vaccinated rhesus monkeys | Q36246220 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Simian immunodeficiency virus | Q1890246 |
| P304 | page(s) | 7521-7535 | |
| P577 | publication date | 2015-05-13 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection | |
| P478 | volume | 89 |
| Q90212716 | Alterations of redox and iron metabolism accompany the development of HIV latency |
| Q26767476 | Animal Models for HIV Cure Research |
| Q40853026 | Cell-mediated anti-Gag immunity in pharmacologically induced functional cure of simian AIDS: a 'bottleneck effect'? |
| Q38823023 | Dual targeting of the thioredoxin and glutathione systems in cancer and HIV. |
| Q59349690 | Mechanisms of abrupt loss of virus control in a cohort of previous HIV controllers |
| Q92465286 | NHC-gold compounds mediate immune suppression through induction of AHR-TGFβ1 signalling in vitro and in scurfy mice |
| Q28077167 | Oxidative Stress during HIV Infection: Mechanisms and Consequences |
| Q39226064 | Tyrosine kinase inhibitors: potential use and safety considerations in HIV-1 infection. |
| Q28077662 | Using animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence research |
Search more.